The race is on to find a new treatment before resistance to today’s drugs becomes widespread.
The third Novartis Social Business stakeholder dialogue took place on November 21 in Basel.
Dr. Matchaba describes how his unique background can help guide the company’s access-to-medicine efforts.
Deep in a forest in the West African country of Ghana, two men are searching for plants that they hope could ultimately provide a cure for some of the world’s deadliest diseases.
David Reddy, CEO Medicines for Malaria Venture and Harald Nusser, Head of Novartis Social Business, explain how new partnerships fight emerging malaria resistance and help eliminate the disease for good.
Great progress has been made against malaria, but signs of resistance are becoming a rising concern
Review the strategy and annual performance of Novartis and read letters from our Chairman and CEO.
This site is intended for a global audience.